20781-06-0Relevant articles and documents
-
Tieckelmann et al.
, p. 1257 (1960)
-
N-(4-substituted phenethyl) acetamide compounds and use thereof
-
Paragraph 0048; 0061-0062, (2017/09/01)
The invention relates to acetamide compounds and a use thereof, and discloses N-(4-substituted phenethyl) acetamide compounds with a novel structure. A result of in-vitro activity test experiments shows that the compounds have inhibitory activity against
Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: In?vitro, spectroscopic, and docking studies
AlNeyadi, Shaikha S.,Salem, Alaa A.,Ghattas, Mohammad A.,Atatreh, Noor,Abdou, Ibrahim M.
, p. 270 - 282 (2017/05/15)
A new series of pyrimidine derivatives 5, 9a-d and 12a-d was synthesized by an efficient procedure. The antibacterial activity of the new compounds was studied against four bacterial strains. Compound 5 was found to exhibit the highest potency, with?=?1.0?μg/ml, against both Escherichia coli and Pseudomonas aeruginosa when compared with amoxicillin (MIC?=?1.0–1.5?μg/mL). Transmission electron microscope results confirmed that activities against bacteria occurred via rupturing of the cell wall. Molecular modeling results suggested that compounds 5, 9a-d and 12a-d have the potential to irreversibly bind to the penicillin-binding protein (PBP) Ser62 residue in the active site and were able to overcome amoxicillin resistance in bacteria by inhibiting the β-lactamase enzyme. Docking studies showed that compounds 5, 9a-d and 12a-d inhibit the β-lactamase enzyme through covalent bonding with Ser70. The synergistic effect with amoxicillin was studied. The newly synthesized compounds reported in this study warrant further consideration as prospective antimicrobial agents.